TEVA Industry: Drug Manufacturers - Other | Teva Pharmaceutical Industries Stock

Dow

0.89% Nasdaq

1.26%

Teva Pharmaceutical Industries Limited (TEVA)

-NYSE

37.80 0.30(0.79%) 4:04PM EDT

Add to Portfolio

Industry: Drug Manufacturers - Other

Get Industry for:

TEVA Sector / Industry Membership

Sector:	Healthcare
Industry:	Drug Manufacturers - Other

Intraday Performance Summary

Name

Ticker

Change

Teva Pharmaceutical Industries Limited

TEVA

0.79%

Drug Manufacturers - Other

^YHOh784

0.50%

View Drug Manufacturers - Other Industry Center

Drug Manufacturers - Other Industry News

Cumberland Pharmaceuticals Earnings: Here’s Why Investors are Buying Shares Nowat Wall St. Cheat Sheet (Thu 7:22PM EDT)
[video] Allergan CEO: FDA Voted In Favor of Volumaat CNBC (Thu 6:15PM EDT)
Two Different Outlooks for Two Tuesday Performersat Motley Fool (Thu 5:20PM EDT)
Allergan's Juvederm Voluma unanimously recommended by FDA Advisory Committeeat theflyonthewall.com (Thu 5:03PM EDT)
FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-FaceBusiness Wire (Thu 4:53PM EDT)

More Industry News...

Top Drug Manufacturers - Other Companies by Market Cap

Company	Symbol	Price	Change	Market Cap	P/E
Novo Nordisk A/S	NVO	172.32	0.10%	93.50B	25.56
Allergan Inc.	AGN	101.31	2.68%	30.20B	28.30
Teva Pharmaceutical Industries Limited	TEVA	37.80	0.79%	32.39B	16.80
Forest Laboratories Inc.	FRX	37.10	0.19%	9.88B	N/A
Dr. Reddy's Laboratories Ltd.	RDY	37.23	0.53%	6.32B	23.20
Pharmacyclics Inc.	PCYC	77.87	2.12%	5.49B	65.88

Showing 1 - 5 of 51 - View All

More Top Companies: by Performance, by Valuation, by Growth, by Growth

TEVA vs. Industry Leaders

Statistic	Industry Leader		TEVA	TEVA Rank
Market Capitalization	NVO	93.50B	32.39B	3 / 51
P/E Ratio (ttm)	GENT	126.00	16.80	12 / 51
PEG Ratio (ttm, 5 yr expected)	SCMP	4.03	1.24	6 / 51
Revenue Growth (Qtrly YoY)	SCMP	153.90%	-7.50%	21 / 51
EPS Growth (Qtrly YoY)	GENT	656.40%	-35.70%	15 / 51
Long-Term Growth Rate (5 yr)	AMRN	74.00%	6.19%	23 / 51
Return on Equity (ttm)	DRRX	81.39%	8.45%	8 / 51
Long-Term Debt/Equity (mrq)			64.363	N/A
Dividend Yield (annual)	WCRX	3.60%	2.80%	2 / 51

View Leaders & Laggards

More on Drug Manufacturers - Other

•	Industry Summary
•	News
•	Leaders & Laggards

•	Company List
•	Industry Calendar

Related Industries

•	Biotechnology
•	Diagnostic Substances
•	Drug Delivery

•	Drug Manufacturers - Major
•	Drug Related Products
•	Drugs - Generic


Top Performing Industries \| Complete Industry List

Currency in USD.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.

Yahoo! Finance

Breaking News Visit Yahoo! News for the latest.

Search for share prices

More On TEVA

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Teva Pharmaceutical Industries Limited (TEVA)